NasdaqCM - Delayed Quote USD
Heron Therapeutics, Inc. (HRTX)
2.1000
+0.1000
+(5.00%)
At close: June 6 at 4:00:01 PM EDT
2.0500
-0.05
(-2.38%)
After hours: June 6 at 7:50:46 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -0.01 | -0 | -0 | 0.05 |
| Low Estimate | -0.02 | -0.01 | -0.02 | 0.05 |
| High Estimate | -0.01 | 0 | 0.01 | 0.05 |
| Year Ago EPS | -0.06 | -0.03 | -0.09 | -0 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 2 |
| Avg. Estimate | 37.93M | 39.62M | 159.28M | 181.05M |
| Low Estimate | 37M | 39.25M | 158.15M | 178.4M |
| High Estimate | 38.8M | 40.1M | 159.9M | 183.7M |
| Year Ago Sales | 36.02M | 32.81M | 144.28M | 159.28M |
| Sales Growth (year/est) | 5.30% | 20.75% | 10.40% | 13.66% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.05 | -0.04 | -0.03 | -0.01 |
| EPS Actual | -0.06 | -0.03 | 0.02 | 0.01 |
| Difference | -0.01 | 0.01 | 0.05 | 0.02 |
| Surprise % | -28.56% | 14.29% | 180.00% | 200.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.01 | -0 | -0 | 0.05 |
| 7 Days Ago | -0.01 | -0.01 | -0.03 | 0.05 |
| 30 Days Ago | -0.01 | -0.01 | -0.03 | 0.05 |
| 60 Days Ago | -0.01 | -0.01 | -0.03 | 0.05 |
| 90 Days Ago | -0.02 | -0.01 | -0.03 | 0.17 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | 1 | -- | -- | -- |
| Down Last 30 Days | 1 | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HRTX | 75.00% | 83.33% | 94.44% | 1,100.00% |
| S&P 500 | 13.13% | 2.48% | 7.55% | 14.01% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 4/11/2025 |
| Reiterates | Needham: Buy to Buy | 2/28/2025 |
| Reiterates | Needham: Buy to Buy | 12/4/2024 |
| Maintains | Needham: Buy to Buy | 11/13/2024 |
| Reiterates | Needham: Buy to Buy | 9/25/2024 |
| Reiterates | Needham: Buy to Buy | 8/7/2024 |
Related Tickers
KPTI Karyopharm Therapeutics Inc.
4.4900
+5.40%
FGEN FibroGen, Inc.
0.3133
+2.69%
ABEO Abeona Therapeutics Inc.
6.74
+4.01%
NKTR Nektar Therapeutics
0.6660
-1.30%
TRVI Trevi Therapeutics, Inc.
7.06
+4.75%
ATRA Atara Biotherapeutics, Inc.
9.23
+8.84%
ALDX Aldeyra Therapeutics, Inc.
2.6600
+8.57%
CLSD Clearside Biomedical, Inc.
0.7865
+1.48%
GOSS Gossamer Bio, Inc.
1.3300
+5.56%
TCRX TScan Therapeutics, Inc.
1.8000
+7.14%